VanEck Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.19M | Sell |
|
|||||
|
2025
Q2 | $7.25M | Sell |
|
|||||
|
2025
Q1 | $5.88M | Buy |
|
|||||
|
2024
Q4 | $6.67M | Buy |
|
|||||
|
2024
Q3 | $1.46M | Buy |
|
|||||
|
2024
Q2 | $2.01M | Buy |
|
|||||
|
2024
Q1 | $2.28M | Sell |
|
|||||
|
2023
Q4 | $2.23M | Sell |
|
|||||
|
2023
Q3 | $1.93M | Buy |
|
|||||
|
2023
Q2 | $2.41M | Sell |
|
|||||
|
2023
Q1 | $2.32M | Buy |
|
|||||
|
2022
Q4 | $1.2M | Buy |
|
|||||
|
2022
Q3 | $503K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $165K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $488K | Buy |
|
|||||
|
2020
Q3 | $181K | Buy |
|